Study: Association between glucagon-like peptide-1 receptor agonists use and change in alcohol consumption: a systematic review.Image Credit: Kmpzzz/Shutterstock.com. In a recent study published ...

About The Article: This Viewpoint discusses the health benefits of glucagon-like peptide-1 receptor agonists (GLP-1 RAs); summarizes the clinical, policy, and equity implications of GLP-1 RA ...

(HealthDay News) — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some individuals, according to a study published online Nov. 14 ...

Dublin, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The "Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast" report has been added to ...

Glucagon-like peptide-1 receptor agonists during pregnancy and lactation Jonathan S. Zipursky , Tali Bogler , Cynthia Maxwell CMAJ Dec 2024, 196 (43) E1413; DOI: 10.1503/cmaj.240768 ...

DALLAS — Results presented at the American Association of Hip and Knee Surgeons Annual Meeting showed 14 days may be the optimal cutoff time for glucagon-like peptide-1 receptor agonists prior ...

DALLAS — Glucagon-like peptide-1 receptor agonists may reduce complications after total knee arthroplasty in patients with obesity but who are not diabetic, according to presented results.&ldquo ...

Review: Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs.Image Credit: Caroline Ruda / Shutterstock. Background ...

Glucagon-like peptide-1 (GLP-1) receptor agonists (also called “glutides”) are an effective treatment for patients with type 2 diabetes and chronic kidney disease In a randomized controlled trial of ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a group of drugs used to treat type 2 diabetes and sometimes obesity. GLP-1 RAs are very effective at lowering blood sugar levels.

Its appetite-suppressing effects led to the development of synthetic analogs called GLP-1 receptor agonists (GLP-1 RAs). These drugs mimic natural GLP-1 by binding to its same receptors.

By Vijay Kumar Malesu Subgroup analyses reveal GLP-1 RAs may reduce alcohol cravings and brain cue reactivity. Study: Association between glucagon-like peptide-1 receptor agonists use and change ...